Portfolio Design Labs LLC Purchases 2,912 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Portfolio Design Labs LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 479.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,519 shares of the medical equipment provider's stock after buying an additional 2,912 shares during the period. Portfolio Design Labs LLC's holdings in Intuitive Surgical were worth $1,729,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. First Horizon Advisors Inc. increased its holdings in shares of Intuitive Surgical by 5.0% in the third quarter. First Horizon Advisors Inc. now owns 6,707 shares of the medical equipment provider's stock valued at $3,295,000 after buying an additional 318 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Intuitive Surgical by 18.9% in the third quarter. Advisors Asset Management Inc. now owns 14,240 shares of the medical equipment provider's stock valued at $6,996,000 after buying an additional 2,265 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Intuitive Surgical in the third quarter valued at $11,356,000. NS Partners Ltd increased its holdings in shares of Intuitive Surgical by 2.3% in the third quarter. NS Partners Ltd now owns 73,518 shares of the medical equipment provider's stock valued at $36,117,000 after buying an additional 1,632 shares in the last quarter. Finally, Kirtland Hills Capital Management LLC increased its holdings in shares of Intuitive Surgical by 15.6% in the third quarter. Kirtland Hills Capital Management LLC now owns 978 shares of the medical equipment provider's stock valued at $480,000 after buying an additional 132 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price target for the company from $380.00 to $510.00 in a report on Friday, August 2nd. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. Finally, Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a "buy" rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $524.61.

Intuitive Surgical Price Performance

ISRG traded up $3.00 during mid-day trading on Wednesday, hitting $541.82. The stock had a trading volume of 984,907 shares, compared to its average volume of 1,456,895. The stock's fifty day simple moving average is $501.42 and its 200-day simple moving average is $460.69. The firm has a market capitalization of $192.98 billion, a price-to-earnings ratio of 86.63, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock valued at $45,897,071 in the last quarter. Company insiders own 0.80% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.